Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
04/08/1995 | CA2132770A1 Aryl and heterocyclic cyanoguanidine derivatives |
04/08/1995 | CA2132766A1 4-arylamino-benzopyran and related compounds |
04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
04/06/1995 | WO1995009184A1 Use of relaxin as an analgesic and palliative for intractable pain |
04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
04/06/1995 | WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
04/06/1995 | WO1995009006A1 Monoglyceride/lactate ester permeation enhancer |
04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
04/06/1995 | CA2167526A1 Monoglyceride/lactate ester permeation enhancer |
04/06/1995 | CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
04/05/1995 | EP0646008A1 Minimizing progestin associated breakthrough bleeding |
04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
04/04/1995 | US5403851 Substituted tryptamines, phenalkylamines and related compounds |
04/04/1995 | US5403847 Use of α1C specific compounds to treat benign prostatic hyperlasia |
03/30/1995 | WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE |
03/29/1995 | EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase |
03/29/1995 | EP0644885A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
03/29/1995 | EP0644770A1 Stabilized somatotropin for parenteral administration |
03/29/1995 | CN1100721A Imidazopyridine |
03/29/1995 | CN1100634A Method of preventing emesis and treating sexual dyfunction using tetra hydrobenzÛCDÙ indole-6-carboxamides |
03/28/1995 | US5401851 Preparation of proline derivatives |
03/28/1995 | US5401776 Use of modafinil for the treatment of urinary and fecal incontinence |
03/28/1995 | US5401758 For treating ischemia |
03/23/1995 | WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof |
03/23/1995 | WO1995007699A1 Novel method of progesterone delivery and affect thereof |
03/23/1995 | WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
03/23/1995 | WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm |
03/23/1995 | WO1995007692A1 Viscous surfactant emulsion compositions |
03/23/1995 | CA2171756A1 Succinamic acid compound, production method thereof and use thereof |
03/23/1995 | CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
03/22/1995 | EP0644194A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof |
03/22/1995 | EP0557301B1 5-fluoro-2,4,6-pyrimidinetriamine compounds for preventing hair loss |
03/22/1995 | EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
03/22/1995 | CN1100416A Derivative of 2-amino-N-ÛÛÛ4-(aminocarbonyl)pyrimidin-2-ylÙamizoÙalkylÙpyrimidiny-4-carboxamide, preparation and pharmaceutical application of same |
03/21/1995 | US5399587 Biologically active compounds |
03/21/1995 | US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
03/21/1995 | US5399550 Physiologically active substance derived or malt and process for the production thereof |
03/21/1995 | US5399359 Controlled release oxybutynin formulations |
03/16/1995 | WO1995007274A1 Bicyclic aromatic compounds as therapeutic agents |
03/16/1995 | WO1995007075A1 Novel aromatic amine derivatives |
03/16/1995 | WO1995003405A3 Enzymatic method for modification of recombinant polypeptides |
03/16/1995 | CA2170056A1 1,4-benzodioxane derivatives for treating cns disorders |
03/15/1995 | EP0642794A1 Pharmaceutical composition for prophylaxis and treatment of premature ejaculation |
03/15/1995 | EP0642529A1 11-g(b)-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS. |
03/15/1995 | EP0642351A1 New pharmaceutical uses of krill enzymes |
03/15/1995 | EP0510028B1 Thioformamide derivatives |
03/14/1995 | US5397776 Vitamin D compounds with anti-progesterone activity |
03/09/1995 | WO1995006634A1 New 9-chloro-prostaglandin derivatives |
03/09/1995 | CA2170613A1 New 9-chloro-prostaglandin derivatives |
03/08/1995 | EP0641791A1 Novel benzothiophene derivative |
03/08/1995 | EP0641565A1 Contraceptive and menstrual cycle controlling drug having oncostatic properties |
03/08/1995 | EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
03/08/1995 | EP0641329A1 Compounds having angiotensine ii antagonistic activity |
03/08/1995 | EP0641326A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties |
03/08/1995 | EP0641302A1 Alcohols as potassium channel openers and in treatment of urinary incontinence |
03/08/1995 | EP0641203A1 Imidazolyl-alkenoic acids |
03/08/1995 | EP0641202A1 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
03/08/1995 | EP0500641B1 Control of milk secretion |
03/07/1995 | US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
03/07/1995 | US5395842 Inhibitors of sex steroids |
03/07/1995 | US5395825 Medical diagnosis of infertility in females |
03/02/1995 | WO1995006046A1 Indole derivatives as thromboxane a2 antagonists |
03/02/1995 | WO1995005822A1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
03/02/1995 | WO1995005821A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones |
03/02/1995 | CA2170279A1 Indole derivatives as thromboxane a2 antagonists |
03/02/1995 | CA2169750A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones |
03/01/1995 | EP0640599A1 4-Aminopyrimidine derivatives |
03/01/1995 | EP0640596A1 N-pyridazinyl-benzene (naphthalene-, biphenyl-) sulfonamide derivatives, their preparation and their use as endothelin antagonists |
03/01/1995 | EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them |
03/01/1995 | EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists |
03/01/1995 | EP0640588A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
03/01/1995 | EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use |
03/01/1995 | EP0639970A1 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
03/01/1995 | EP0518908B1 Method for polymerization of epoxide compounds |
03/01/1995 | CA2130971A1 Sulfonamide endothelin antagonists |
02/28/1995 | US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them |
02/28/1995 | US5393747 Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists |
02/23/1995 | WO1995005188A1 Erection-inducing methods and compositions |
02/23/1995 | WO1995005172A1 Methods for modulating the human sexual response |
02/22/1995 | EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it |
02/22/1995 | EP0639377A1 Vitamin D compounds with anti-progesterone activity |
02/21/1995 | US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses |
02/16/1995 | WO1995004730A1 Benzopyrans and pharmaceutical compositions containing them |
02/16/1995 | WO1995004541A1 N-terminus modified analogs of lhrh |
02/16/1995 | WO1995004530A1 Endothelin receptor antagonists |
02/16/1995 | CA2167834A1 N-terminus modified analogs of lhrh |
02/15/1995 | EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them |
02/15/1995 | EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
02/15/1995 | EP0389570B1 High integrity liposomes and method of preration and use |
02/15/1995 | CN1098625A Composition |
02/14/1995 | US5389676 A water in oil or oil in water antibacterial emulsion comprising betaines and amine oxides, hydrophobic materials, water soluble nonionic, cationic surfactants; stability, bactericides, antiseptics; soap, shampoo, wound healing agent |
02/14/1995 | US5389670 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
02/14/1995 | US5389668 Thiochroman compounds |
02/14/1995 | US5389655 Treats angina pectoris |
02/14/1995 | US5389634 Imidazole derivatives having angiotensin II receptor antagonistic activity |
02/14/1995 | CA1334390C Glycoprotein growth modulation materials |
02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
02/09/1995 | WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
02/09/1995 | WO1995004051A1 Piperazine compounds used in therapy |